1Spencer FA, Bates SM, Goldberg RJ, et al. A population based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med,2010,170 (16) : 1456 - 1462.
2Kearon C, Akl EA, Comerota A J, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed : American College of Chest Physicians evidencebased clinical practice guidelines. Chest,2012,141 (2 Suppl) : e419S - e494S.
3Hajduk B, Tomkowski WZ, Malek G, et al. Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest,2010,137(4) :877 - 882.
4Imberti D, Ageno W, Manfredini R, et al. Interventional treatment of venous thromboembolism : a review. Thrornb Res,2012,129 (4) : 418 -425.
5Rimon U, Volkov A, Garniek A, et al. Histology of tissue adherent to OptEase inferior vena cava filters regarding indwelling time, Cardiovasc Intervent Radiol,2009,32 ( 1 ) :93 - 96.
7Imberti D, Ageno W. Dentali F. Retrievable vena cava filters: a clinical review. J Thromb Thrombolysis, 2012,33 ( 3 ) : 258 - 266.
8Asch MR. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology,2002,225 ( 3 ) : 835 - 844.
9Reekers JA, Hoogeveen YL, Wijnands M, et al. Evaluation of the retrievability of the OptEase IVC filter in an animal model. J Vase Interv Radiol,2004,15 ( 3 ) :261 - 267.
10Rimon U, Bensaid P, Golan G, et al. OptEase vena cava filter optimal indwelling time and retrievability. Cardiovasc Interv Radiol, 2011,34(3) :532 -535.
